UCLA Ginsburg Symposium in Precision Health

Precision Health

Event Information  

The David Geffen School of Medicine and UCLA Institute for Precision Health hosted the first Annual Ginsburg Symposium in Genomic Medicine: Frontiers in Gene Editing on May 11, 2022 at UCLA's Carnesale Commons. This full-day symposium highlighted progress and challenges in the therapeutic applications of gene-editing technology and associated ethical and regulatory issues.

The symposium included a keynote speaker, panel discussion, posters and oral presentations. A catered reception and awards ceremony followed. Students, postdocs, faculty, and staff from all campuses were invited to attend.

All graduate students and postdoctoral fellows were encouraged to submit an abstract for the poster session. Three abstracts were selected for oral presentations during a lightning round. Those not selected for the lightning round were still given the opportunity to present a poster during the symposium lunch hour.

Keynote Speakers

Jennifer Doudna

Jennifer Doudna, PhD

Manager, UCLA Biobank
Manager, Translational Pathology Core Laboratory (TCPL)
Director, Image Analysis/Virtual Microscopy

David Liu

David Liu, PhD

Richard Merkin Professor and Director of the Merkin Institute of Transformative Technologies in Healthcare
Vice Chair of the faculty at the Broad Institute of Harvard and MIT
Thomas Dudley Cabot Professor of the Natural Sciences at Harvard University
Howard Hughes Medical Institute (HHMI) investigator

Symposium Speakers

Donald B. Kohn, MD

Donald B. Kohn, MD

Pediatric Hematologic Malignancy

Distinguished Professor of Microbiology, Immunology and Molecular Genetics
Pediatrics (Hematology/Oncology)
Molecular and Medical Pharmacology at the University of California, Los Angeles

Yvonne Chen

Yvonne Chen, PhD

Associate Professor of Microbiology, Immunology, and Molecular Genetics at the University of California, Los Angeles

Tippi MacKenzie

Tippi MacKenzie, MD

Professor of Surgery of University of California San Francisco Division of Pediatric Surgery and the Fetal Treatment Center

R. Alto Charo

R. Alta Charo, JD

Principal, Alta Charo Consulting LLC and Knowles Professor Emerita of Law & Bioethics, University of Wisconsin – Madison

Diane Berry

Diane Berry , PhD

Senior Vice President, Global Policy, Government & Patient Affairs at Sarepta Therapeutics

Emil Kakkis

Emil Kakkis, MD, PhD

Chief Executive Officer, President and Director of Ultragenyx

Peter Marks

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration

For any questions, please contact William Weil - [email protected]